# The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm

> **NCT02682446** · — · COMPLETED · sponsor: **Kyungpook National University Hospital** · enrollment: 800 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** H pylori eradication

## Key facts

- **NCT ID:** NCT02682446
- **Lead sponsor:** Kyungpook National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2016-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682446, "The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02682446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*